PAVM PAVmed Inc.
PAVmed Inc. (PAVM) is expected to report earnings on November 13, 2026, before the market open. The consensus earnings estimate is a loss of $0.66 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +10.6% since its last earnings release on August 14, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About PAVmed Inc.
PAVmed Inc. is a highly differentiated, multi-product, commercial-stage medical technology company with a diversified product pipeline addressing unmet clinical needs encompassing a broad spectrum of clinical areas with attractive regulatory pathways and market opportunities.
Sector
Healthcare
Industry
Medical Instruments/Supply